.: OLGU SUNUMU
Üç Olguda Endojen Fungal Endoftalmide Pars Plana Vitrektomi Sonuçları
Results of Pars Plana Vitrectomy in Endogenous Fungal Endophthalmitis in 3 Cases
Turkiye Klinikleri J Ophthalmol. 2020;29(1):96-102
doi: 10.5336/ophthal.2019-65505
Makale Dili: TR
Tam Metin
ÖZET
Endojen fungal endoftalmi, fungal etkenin hematojen yolla oküler dokulara ulaşmasına bağlı gelişir. Yıkıcı oküler komplikasyonlara yol açabilen, hızlı tanı ve uygun tedavi gerektiren intraoküler bir enfeksiyondur. Endojen fungal endoftalmi tedavisi için standart rejimler sistemik antifungaller, intravitreal antifungal enjeksiyonlar ve pars plana vitrektomidir. Bu çalışmada; bilateral endojen fungal endoftalmi nedeni ile izlenen, sistemik ve/veya intravitreal antifungal tedavi alan üç olguda pars plana vitrektominin terapötik etkisinin sonuçlarının sunulması amaçlanmıştır.
Anahtar Kelimeler: Endojen endoftalmi; fungal endoftalmi; kandida endoftalmisi; vitrektomi
Endojen fungal endoftalmi, fungal etkenin hematojen yolla oküler dokulara ulaşmasına bağlı gelişir. Yıkıcı oküler komplikasyonlara yol açabilen, hızlı tanı ve uygun tedavi gerektiren intraoküler bir enfeksiyondur. Endojen fungal endoftalmi tedavisi için standart rejimler sistemik antifungaller, intravitreal antifungal enjeksiyonlar ve pars plana vitrektomidir. Bu çalışmada; bilateral endojen fungal endoftalmi nedeni ile izlenen, sistemik ve/veya intravitreal antifungal tedavi alan üç olguda pars plana vitrektominin terapötik etkisinin sonuçlarının sunulması amaçlanmıştır.
Anahtar Kelimeler: Endojen endoftalmi; fungal endoftalmi; kandida endoftalmisi; vitrektomi
ABSTRACT
Endogenous fungal endophthalmitis occurs via hematogenous spread of fungal agents to ocular tissues. It is an intraocular infection that can result in devastating ocular complications and requires immediate diagnosis and appropriate treatment. Standard regimens for endogenous fungal endophthalmitis treatment alternatives are systemic antifungals, intravitreal antifungal injections, and pars plana vitrectomy. In this study; we aimed to present the results of the therapeutic effect of pars plana vitrectomy in three cases, who received systemic and/or intravitreal antifungal therapy for bilateral endogenous fungal endophthalmitis.
Keywords: Endogenous endophthalmitis; fungal endophthalmitis; candida endophthalmitis; vitrectomy
Endogenous fungal endophthalmitis occurs via hematogenous spread of fungal agents to ocular tissues. It is an intraocular infection that can result in devastating ocular complications and requires immediate diagnosis and appropriate treatment. Standard regimens for endogenous fungal endophthalmitis treatment alternatives are systemic antifungals, intravitreal antifungal injections, and pars plana vitrectomy. In this study; we aimed to present the results of the therapeutic effect of pars plana vitrectomy in three cases, who received systemic and/or intravitreal antifungal therapy for bilateral endogenous fungal endophthalmitis.
Keywords: Endogenous endophthalmitis; fungal endophthalmitis; candida endophthalmitis; vitrectomy
REFERANSLAR:
- Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227-34. [Crossref] [PubMed] [PMC]
- Turgut-Çoban D, Erol MK, Çoban AY. [Causative agents of endophthalmitis in Turkey: an overview]. Klimik Dergisi. 2013;26(2):44-8. [Crossref]
- Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand. 2007;85(8):852-6. [Crossref] [PubMed]
- Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597-613. [Crossref] [PubMed] [PMC]
- Rao NA, Hidayat AA. Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol. 2001;132(2):244-51. [Crossref]
- Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE Jr, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101(7):1302-9. [Crossref]
- Hu CC, Ho JD, Lou HY, Keller JJ, Lin HC. A one-year follow-up study on the incidence and risk of endophthalmitis after pyogenic liver abscess. Ophthalmology. 2012;119(11):2358-63. [Crossref] [PubMed]
- Chen KJ, Wu WC, Sun MH, Lai CC, Chao AN. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;154(1):213-4. [Crossref] [PubMed]
- Lee S, Um T, Joe SG, Hwang JU, Kim JG, Yoon YH, et al. Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina. 2012;32(5):977-84. [Crossref] [PubMed]
- Lei B, Jiang R, Gu R, Xu G, Song F, Zhou M. Endogenous fungal endophthalmitis associated with genitourinary procedures. Ocul Immunol Inflamm. 2019;27(5):747-55. [Crossref] [PubMed]
- Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137(4):725-31. [Crossref] [PubMed]
- Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990;162(1):115-20. [Crossref] [PubMed]
- Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3(1):60. [Crossref] [PubMed] [PMC]
- Düzgün E, Çakır A, Ünal MH, Sönmez M, Ayata A, Yıldırım Y, et al. [Endogenous candida endophthalmitis: treatment options]. Ret Vit. 2014;22(2):159-67.
- Chavan R, Mustafa MZ, Narendran N, Tarin S, Yang Y. A case of candida albicans endophthalmitis with no predisposing risk factors and a distant source of infection. Case Rep Ophthalmol. 2012;3(3):277-82. [Crossref] [PubMed] [PMC]
- Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;153(1):162-6.e1. [Crossref] [PubMed]
- Smith JM, Mathias MT, Oliver SC, Mandava N, Olson JL, Quiroz-Mercado H, et al. The influence of needle gauge and infection source on vitreous aspirate cultures. Br J Ophthalmol. 2016;100(4):453-5. [Crossref] [PubMed]
- Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm. 2009;17(3):148-52. [Crossref] [PubMed]
- Anand A, Madhavan H, Neelam V, Lily T. Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. Ophthalmology. 2001;108(2):326-30. [Crossref]
- Chee YE, Eliott D. The role of vitrectomy in the management of fungal endophthalmitis. Semin Ophthalmol. 2017;32(1):29-35. [Crossref] [PubMed]
- Gökmen O, Bayar SA. [Endophthalmitis clinical features and treatment]. Journal of Retina-Vitreous. 2014;22(3):242-7.
- O'Day DM, Head WS, Robinson RD, Stern WH, Freeman JM. Intraocular penetration of systemically administered antifungal agents. Curr Eye Res. 1985;4(2):131-4. [Crossref] [PubMed]
- Baldinger J, Doft BH, Burns SA, Johnson B. Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes. Br J Ophthalmol. 1986;70(9):657-61. [Crossref] [PubMed] [PMC]
- Riddell J 4th, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52(5):648-53. [Crossref] [PubMed]
- Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina. 2006;26(8):935-9. [Crossref] [PubMed]
- Martínez-Vázquez C, Fernández-Ulloa J, Bordón J, Sope-a B, de la Fuente J, Ocampo A, et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis. 1998;27(5):1130-3. [Crossref] [PubMed]
- Sallam A, Taylor SR, Khan A, McCluskey P, Lynn WA, Manku K, et al. Factors determining visual outcome in endogenous Candida endophthalmitis. Retina. 2012;32(6):1129-34. [Crossref] [PubMed]
- Birnbaum FA, Gupta G. The role of early vitrectomy in the treatment of fungal endogenous endophthalmitis. Retin Cases Brief Rep. 2016;10(3):232-5. [Crossref] [PubMed]
- Lin P, Wynn P, Stewart JM. Management of a recalcitrant candidal chorioretinal abscess. Retin Cases Brief Rep. 2012;6(3):280-4. [Crossref] [PubMed]
- Celiker H, Kazokoglu H. The role of pars plana vitrectomy in the management of fungal endogenous endophthalmitis. Eur J Ophthalmol. 2018 Nov 26. Doi: 10.1177/1120672118815105. [Epub ahead of print]. [Crossref] [PubMed]
- Malton ML, Rinkoff JS, Doft BS, Kennerdell JS. Cryptococcal endophthalmitis and meningitis associated with acute psychosis and exudative retinal detachment. Am J Ophthalmol. 1987;104(4):438-9. [Crossref]
- Recchia FM, Shah GK, Eagle RC, Sivalingam A, Fischer DH. Visual and anatomical outcome following submacular surgery for choroidal neovascularization secondary to Candida endophthalmitis. Retina. 2002;22(3):323-9. [Crossref] [PubMed]
- Kusaka S, Hayashi N, Ohji M, Ikuno Y, Gomi F, Tano Y. Macular hole secondary to fungal endophthalmitis. Arch Ophthalmol. 2003;121(5):732-3. [Crossref] [PubMed] [PMC] PMID: 12742858. https://doi.org/10.1001/archopht.121.5.732 PMid:12742858
- Naoi N, Sawada A. Effect of vitrectomy on epiretinal membranes after endogenous fungal endophthalmitis. Jpn J Ophthalmol. 1996;40(3):434-8.
.: İşlem Listesi